AC Immune Reports Positive Week-100 VacSYn Phase 2 Data
LAUSANNE, Switzerland — September 23, 2026 AC Immune SA reported positive safety and immunogenicity results through Week 100 from...
Parkinson’s Disease
Advertisement
CND Life Sciences Opens New Innovation Lab in Scottsdale
Scottsdale, Arizona, U.S., September 17, 2026 CND Life Sciences, Inc., a medical technology company focused on neurodiagnostic testing and...
Enable Biosciences Gains Brazil Approval for T1D Test
South San Francisco, California, U.S., September 17, 2026 Enable Biosciences, Inc. has announced that Brazil’s National Health Surveillance Agency...
1ST Biotherapeutics and SK Biopharma License Parkinson’s Drug
Yongin, South Korea, September 17, 2026 1ST Biotherapeutics, Inc. (1STBIO) and SK Biopharmaceuticals Co., Ltd. (SKBP) have announced an...
Aptar Pharma and MGH Advance Nose-to-Brain Drug Delivery
CRYSTAL LAKE, Ill. — September 14, 2026 Aptar Pharma and Massachusetts General Hospital (MGH) announced a research collaboration led...
Advertisements
Insightec Reaches 10,000 EMEA Patients With MRgFUS
HAIFA, Israel and FRANKFURT, Germany — September 8, 2026 Insightec announced that more than 10,000 patients across Europe, the...
American Regent Recalls Epinephrine Injection Over Sterility
Shirley, New York, September 3, 2026 American Regent, Inc. has initiated a voluntary nationwide recall of three lots of...
Thryv Licenses New SGK1 Inhibitors for Neurodegeneration
San Francisco, California, September 3, 2026 Thryv Therapeutics Inc., a clinical-stage biopharmaceutical company developing selective SGK1 inhibitors, has entered...
ONWARD Medical Begins EIGER Study With First ARC-IM Implant
Eindhoven, Netherlands, September 3, 2026 ONWARD Medical announced the first implant in the new EIGER clinical feasibility study, evaluating...
Zambon Announces European Commission Approval of Hopledo for Parkinson’s Disease Motor Fluctuations
Milan, Italy – August 28, 2026 Zambon announced that the European Commission has granted marketing authorization for Hopledo® (modified-release...
Advertisement
